Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design

被引:98
作者
Streubel, A
Siepmann, J
Peppas, NA
Bodmeier, R
机构
[1] Univ Angers, Coll Pharm, F-49100 Angers, France
[2] Free Univ Berlin, Coll Pharm, D-12169 Berlin, Germany
[3] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA
关键词
bimodal drug release; multi-layer tablet; release mechanism; modeling; HPMCAS;
D O I
10.1016/S0168-3659(00)00334-5
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
The aim of this study was to develop new multi-layer matrix tablets to achieve bimodal drug release profiles (fast release/slow release/fast release). Hydroxypropyl methylcellulose acetate succinate (HPMCAS, type MF) was chosen as a matrix former, because it is water-insoluble at low, and water-soluble at high pH values. Studies focused on the elucidation of the drug release mechanisms from HPMCAS-MF:drug tablets. In 0.1 N HCl the resulting release kinetics can be described using Fick's second law of diffusion, taking into account axial and radial mass transfer in cylindrical geometry. As the diffusion coefficients are found to be constant and the boundary conditions to be stationary, these systems are purely drug diffusion-controlled In contrast, the dominating mass transport phenomena in phosphate buffer pH 7.4 are more complex. Due to polymer dissolution the resulting matrix structure is time-variant, leading to increasing drug diffusion coefficients and decreasing tablet dimensions, and thus moving boundary conditions. Drug release is affected by water imbibition, drug diffusion and polymer dissolution and is faster compared to 0.1 N HCl. With knowledge of these underlying release mechanisms, multi-layer matrix tablets were developed to achieve bimodal drug release. HPMCAS-MF:drug mixtures were used as tablet cores. As expected, changing the release medium from 0.1 N HCl to phosphate buffer pH 7.4 after 2 h, lead to a significant increase in drug release. The abruptness of this rate change could be enhanced by adding two drug-free HPMCAS-MF barrier layers tone on each side) to the system. The addition of a fourth, drug-containing and fast disintegrating initial dose layer yielded the desired bimodal drug release patterns. Tie process and formulation parameters affecting the resulting release rates were investigated using theophylline and acetaminophen as model drugs. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:455 / 468
页数:14
相关论文
共 31 条
[1]
SWELLING AND DRUG-RELEASE IN HYDROGEL MATRICES - POLYMER VISCOSITY AND MATRIX POROSITY EFFECTS [J].
BETTINI, R ;
COLOMBO, P ;
MASSIMO, G ;
CATELLANI, PL ;
VITALI, T .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 2 (03) :213-219
[2]
EVALUATION OF BIODEGRADABLE POLY(LACTIDE) PELLETS PREPARED BY DIRECT COMPRESSION [J].
BODMEIER, R ;
CHEN, HG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (10) :819-822
[3]
Formulation and characterization of new layered diffusional matrices for zero-order sustained release [J].
Chidambaram, N ;
Porter, W ;
Flood, K ;
Qiu, YH .
JOURNAL OF CONTROLLED RELEASE, 1998, 52 (1-2) :149-158
[4]
DRUG RELEASE MODULATION BY PHYSICAL RESTRICTIONS OF MATRIX SWELLING [J].
COLOMBO, P ;
CONTE, U ;
GAZZANIGA, A ;
MAGGI, L ;
SANGALLI, ME ;
PEPPAS, NA ;
LAMANNA, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 63 (01) :43-48
[5]
SWELLING CHARACTERISTICS OF HYDROPHILIC MATRICES FOR CONTROLLED RELEASE NEW DIMENSIONLESS NUMBER TO DESCRIBE THE SWELLING AND RELEASE BEHAVIOR [J].
COLOMBO, P ;
CATELLANI, PL ;
PEPPAS, NA ;
MAGGI, L ;
CONTE, U .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 88 (1-3) :99-109
[6]
COLOMBO P, 1994, Patent No. 0598309
[7]
Conte U, 1989, US Patent, Patent No. [4,839,177 A, 4839177, 4,839,177]
[8]
Crank J, 1979, MATH DIFFUSION
[9]
Fan L., 1989, Controlled release: A quantitative treatment
[10]
Fujita H., 1961, Adv Polym Sci, V3, P1, DOI DOI 10.1007/BFB0050514